{"id":31557,"date":"2025-04-10T15:58:35","date_gmt":"2025-04-10T07:58:35","guid":{"rendered":"https:\/\/flcube.com\/?p=31557"},"modified":"2025-04-10T15:58:36","modified_gmt":"2025-04-10T07:58:36","slug":"iview-therapeutics-iview-1201-gains-fda-orphan-drug-designation-for-fungal-keratitis","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=31557","title":{"rendered":"IVIEW Therapeutics&#8217; IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis"},"content":{"rendered":"\n<p>China-based IVIEW Therapeutics Inc. announced that it has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for IVIEW-1201, a 1.0% povidone iodine eye gel sterile solution. This designation is for the treatment of fungal keratitis (FK), a serious eye infection caused by filamentous fungi or yeast affecting the cornea.<\/p>\n\n\n\n<p><strong>Disease Background<\/strong><br>Fungal keratitis is a severe ocular disease that poses a significant threat to vision, often leading to vision loss or blindness if left untreated. The condition is typically caused by infections from filamentous fungi or yeast, emphasizing the critical need for effective antifungal therapies.<\/p>\n\n\n\n<p><strong>Current Treatment Landscape<\/strong><br>Currently, Natacyn (natamycin), developed by Harrow, Inc., is the only FDA-approved topical ophthalmic antifungal for fungal keratitis. IVIEW-1201 represents a novel approach to addressing this condition, offering a new treatment option for patients with limited therapeutic choices.<\/p>\n\n\n\n<p><strong>IVIEW-1201 Mechanism<\/strong><br>IVIEW-1201 is a sterile solution containing 1.0% povidone iodine, a broad-spectrum antiseptic. Its mechanism of action involves disrupting fungal cell membranes, making it effective against a range of pathogens responsible for fungal keratitis. This innovative formulation is designed to provide targeted antifungal activity while minimizing systemic exposure.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China-based IVIEW Therapeutics Inc. announced that it has received Orphan Drug Designation (ODD) from the&#8230;<\/p>\n","protected":false},"author":1,"featured_media":31559,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,11],"tags":[3180,44],"class_list":["post-31557","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-drug","tag-iview-therapeutics","tag-ophthalmology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>IVIEW Therapeutics&#039; IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based IVIEW Therapeutics Inc. announced that it has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for IVIEW-1201, a 1.0% povidone iodine eye gel sterile solution. This designation is for the treatment of fungal keratitis (FK), a serious eye infection caused by filamentous fungi or yeast affecting the cornea.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=31557\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIEW Therapeutics&#039; IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis\" \/>\n<meta property=\"og:description\" content=\"China-based IVIEW Therapeutics Inc. announced that it has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for IVIEW-1201, a 1.0% povidone iodine eye gel sterile solution. This designation is for the treatment of fungal keratitis (FK), a serious eye infection caused by filamentous fungi or yeast affecting the cornea.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=31557\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-10T07:58:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-10T07:58:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1012-png.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31557#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31557\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"IVIEW Therapeutics&#8217; IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis\",\"datePublished\":\"2025-04-10T07:58:35+00:00\",\"dateModified\":\"2025-04-10T07:58:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31557\"},\"wordCount\":202,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31557#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1012-png.webp\",\"keywords\":[\"IVIEW Therapeutics\",\"Ophthalmology\"],\"articleSection\":[\"Company\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31557#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31557\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=31557\",\"name\":\"IVIEW Therapeutics' IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31557#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31557#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1012-png.webp\",\"datePublished\":\"2025-04-10T07:58:35+00:00\",\"dateModified\":\"2025-04-10T07:58:36+00:00\",\"description\":\"China-based IVIEW Therapeutics Inc. announced that it has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for IVIEW-1201, a 1.0% povidone iodine eye gel sterile solution. This designation is for the treatment of fungal keratitis (FK), a serious eye infection caused by filamentous fungi or yeast affecting the cornea.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31557#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31557\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31557#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1012-png.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1012-png.webp\",\"width\":1080,\"height\":608,\"caption\":\"IVIEW Therapeutics' IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31557#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIEW Therapeutics&#8217; IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"IVIEW Therapeutics' IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis - Insight, China&#039;s Pharmaceutical Industry","description":"China-based IVIEW Therapeutics Inc. announced that it has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for IVIEW-1201, a 1.0% povidone iodine eye gel sterile solution. This designation is for the treatment of fungal keratitis (FK), a serious eye infection caused by filamentous fungi or yeast affecting the cornea.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=31557","og_locale":"en_US","og_type":"article","og_title":"IVIEW Therapeutics' IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis","og_description":"China-based IVIEW Therapeutics Inc. announced that it has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for IVIEW-1201, a 1.0% povidone iodine eye gel sterile solution. This designation is for the treatment of fungal keratitis (FK), a serious eye infection caused by filamentous fungi or yeast affecting the cornea.","og_url":"https:\/\/flcube.com\/?p=31557","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-04-10T07:58:35+00:00","article_modified_time":"2025-04-10T07:58:36+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1012-png.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=31557#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=31557"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"IVIEW Therapeutics&#8217; IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis","datePublished":"2025-04-10T07:58:35+00:00","dateModified":"2025-04-10T07:58:36+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=31557"},"wordCount":202,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=31557#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1012-png.webp","keywords":["IVIEW Therapeutics","Ophthalmology"],"articleSection":["Company","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=31557#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=31557","url":"https:\/\/flcube.com\/?p=31557","name":"IVIEW Therapeutics' IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=31557#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=31557#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1012-png.webp","datePublished":"2025-04-10T07:58:35+00:00","dateModified":"2025-04-10T07:58:36+00:00","description":"China-based IVIEW Therapeutics Inc. announced that it has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for IVIEW-1201, a 1.0% povidone iodine eye gel sterile solution. This designation is for the treatment of fungal keratitis (FK), a serious eye infection caused by filamentous fungi or yeast affecting the cornea.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=31557#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=31557"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=31557#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1012-png.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1012-png.webp","width":1080,"height":608,"caption":"IVIEW Therapeutics' IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=31557#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"IVIEW Therapeutics&#8217; IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1012-png.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31557"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31557\/revisions"}],"predecessor-version":[{"id":31560,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31557\/revisions\/31560"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/31559"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}